Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 0.3248 | 0.8921 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0054 | 0.1192 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.024 | 0.0919 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0024 | 0.0376 | 0.651 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma cruzi | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.0577 | 0.4843 |
Entamoeba histolytica | Flap nuclease, putative | 0.0031 | 0.0577 | 1 |
Mycobacterium leprae | PROBABLE CATION-TRANSPORTER P-TYPE ATPASE B CTPB | 0.001 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Echinococcus multilocularis | dna polymerase kappa | 0.0023 | 0.0356 | 0.109 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0356 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.1359 | 0.3732 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0356 | 0.109 |
Plasmodium falciparum | flap endonuclease 1 | 0.0031 | 0.0577 | 1 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0019 | 0.024 | 0.066 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2614 | 0.7182 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.364 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0023 | 0.0356 | 0.1361 |
Echinococcus granulosus | transcription factor eb | 0.013 | 0.3265 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0159 | 0.1337 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.0356 | 0.6167 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.024 | 0.0919 |
Brugia malayi | Helix-loop-helix DNA-binding domain containing protein | 0.013 | 0.3265 | 0.8968 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0023 | 0.0356 | 0.2986 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1224 | 0.3748 |
Leishmania major | DNA polymerase eta, putative | 0.0054 | 0.1192 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | FMN-dependent NADH-azoreductase, putative | 0.0024 | 0.0376 | 0.0376 |
Echinococcus multilocularis | flap endonuclease 1 | 0.0031 | 0.0577 | 0.1768 |
Entamoeba histolytica | iron-sulfur flavoprotein, putative | 0.0024 | 0.0376 | 0.651 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.0841 | 0.3217 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.0841 | 0.231 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0023 | 0.0356 | 0.1361 |
Echinococcus multilocularis | transcription factor eb | 0.013 | 0.3265 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.024 | 0.0919 |
Echinococcus granulosus | GPCR family 2 | 0.0019 | 0.024 | 0.0736 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.1224 | 0.3748 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.1359 | 0.3732 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0356 | 0.2986 |
Schistosoma mansoni | hypothetical protein | 0.0019 | 0.024 | 0.0919 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Brugia malayi | hypothetical protein | 0.0106 | 0.2614 | 0.7182 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0356 | 0.6167 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1224 | 0.4681 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0356 | 0.0978 |
Trypanosoma brucei | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.0577 | 0.4843 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.024 | 0.0736 |
Trichomonas vaginalis | flap endonuclease-1, putative | 0.0031 | 0.0577 | 0.0577 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0356 | 0.2986 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0356 | 0.0356 |
Loa Loa (eye worm) | hypothetical protein | 0.0106 | 0.2614 | 0.7182 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0356 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Mycobacterium leprae | PROBABLE CATION-TRANSPORTER ATPASE I CTPI | 0.001 | 0 | 0.5 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Schistosoma mansoni | eyes absent homolog | 0.0106 | 0.2614 | 1 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1224 | 0.3748 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.024 | 0.0736 |
Brugia malayi | Flap endonuclease-1 | 0.0031 | 0.0577 | 0.1586 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Treponema pallidum | cation-transporting ATPase, P-type | 0.001 | 0 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0159 | 0.1337 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0054 | 0.1192 | 0.3274 |
Chlamydia trachomatis | metal transport ATPase | 0.001 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.0841 | 0.231 |
Treponema pallidum | hypothetical protein | 0.001 | 0 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Loa Loa (eye worm) | hypothetical protein | 0.0019 | 0.024 | 0.066 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0019 | 0.024 | 0.0736 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0019 | 0.024 | 0.066 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.1224 | 0.3361 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0023 | 0.0356 | 0.0978 |
Entamoeba histolytica | modulator of drug activity B homolog, putative | 0.0024 | 0.0376 | 0.651 |
Leishmania major | flap endonuclease-1 (FEN-1), putative | 0.0031 | 0.0577 | 0.4843 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Echinococcus granulosus | dna polymerase kappa | 0.0023 | 0.0356 | 0.109 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0024 | 0.0376 | 0.651 |
Echinococcus multilocularis | GPCR, family 2 | 0.0019 | 0.024 | 0.0736 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1224 | 0.4681 |
Giardia lamblia | Flap structure-specific endonuclease | 0.0031 | 0.0577 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0038 | 0.0755 | 0.6336 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trypanosoma brucei | unspecified product | 0.0023 | 0.0356 | 0.2986 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0055 | 0.1224 | 0.3748 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0019 | 0.024 | 0.066 |
Mycobacterium leprae | Probable metal cation-transporting P-type ATPase C CtpC | 0.001 | 0 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0023 | 0.0356 | 0.2986 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.364 | 1 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0356 | 0.0356 |
Loa Loa (eye worm) | helix-loop-helix DNA-binding domain-containing protein | 0.013 | 0.3248 | 0.8921 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0019 | 0.024 | 0.0736 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0378 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.1224 | 0.4681 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.364 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.1359 | 0.3732 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Loa Loa (eye worm) | flap endonuclease-1 | 0.0031 | 0.0577 | 0.1586 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0356 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0356 | 1 |
Schistosoma mansoni | flap endonuclease-1 | 0.0028 | 0.0495 | 0.1894 |
Echinococcus granulosus | dna polymerase eta | 0.0054 | 0.1192 | 0.3651 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.1359 | 0.3732 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1192 | 0.3274 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | unspecified product | 0.0016 | 0.0159 | 0.1337 |
Entamoeba histolytica | hypothetical protein | 0.0024 | 0.0376 | 0.651 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0016 | 0.0159 | 0.1337 |
Onchocerca volvulus | 0.001 | 0 | 0.5 | |
Leishmania major | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Toxoplasma gondii | flap structure-specific endonuclease 1, putative | 0.0031 | 0.0577 | 0.7644 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.1224 | 0.3361 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0038 | 0.0755 | 0.6336 |
Plasmodium vivax | flap endonuclease 1, putative | 0.0031 | 0.0577 | 1 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0038 | 0.0755 | 1 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0023 | 0.0356 | 0.109 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma brucei | unspecified product | 0.0016 | 0.0159 | 0.1337 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Echinococcus granulosus | flap endonuclease 1 | 0.0031 | 0.0577 | 0.1768 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0024 | 0.0376 | 0.651 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0054 | 0.1192 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0024 | 0.0376 | 0.0376 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Echinococcus multilocularis | dna polymerase eta | 0.0054 | 0.1192 | 0.3651 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0023 | 0.0356 | 0.2986 |
Trichomonas vaginalis | modulator of drug activity B, putative | 0.0024 | 0.0376 | 0.0376 |
Schistosoma mansoni | DNA polymerase eta | 0.0054 | 0.1192 | 0.4559 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.7 uM | Inihibition of human recombinant NQO1 | ChEMBL. | 17011189 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.